ALXN

Alexion Pharmaceuticals, Inc. News Headlines

$168.94
*  
0.82
0.48%
Get ALXN Alerts
*Delayed - data as of Aug. 20, 2014 11:08 ET  -  Find a broker to begin trading ALXN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALXN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog
8/19/2014 5:25:00 PM - Zacks.com

12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds
8/10/2014 10:54:00 AM - Seeking Alpha

Alnylam Pharmaceuticals Has Plenty On Its Plate
8/9/2014 10:36:00 AM - Seeking Alpha

VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales - Analyst Blog
8/8/2014 11:00:00 AM - Zacks.com

Orexigen Therapeutics Reports Wider Q2 Loss as Costs Mount - Analyst Blog
8/8/2014 9:20:00 AM - Zacks.com

NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales - Analyst Blog
8/7/2014 12:40:00 PM - Zacks.com

Vertex's Price And Prospects Compared To Alexion
8/7/2014 10:50:00 AM - Seeking Alpha

Noteworthy ETF Inflows: TQQQ, ATVI, AKAM, ALXN
8/6/2014 10:49:53 AM - BNK Invest

Actavis Beats on Q2 Earnings & Revs, Provides 2015 Outlook - Analyst Blog
8/5/2014 2:00:00 PM - Zacks.com

Alkermes Reports Loss in Q2 on Higher Costs, Revenues Up - Analyst Blog
8/4/2014 3:40:00 PM - Zacks.com

Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss - Analyst Blog
8/4/2014 11:10:00 AM - Zacks.com

Dr. Reddy's (RDY) Q1 Earnings and Revenues Rise Y/Y - Analyst Blog
8/1/2014 3:20:00 PM - Zacks.com

Alexion : EC Grants Orphan Drug Designation To Soliris To Treat Patients With MG
8/1/2014 6:39:00 AM - RTT News

Aegerion Q2 Loss Narrower than Expected, 2014 View Retained - Analyst Blog
7/30/2014 3:15:00 PM - Zacks.com

Biotech ETF Price Swings May Signal Need For Caution
7/28/2014 6:03:00 PM - Investor's Business Daily

Nasdaq 100 Movers: MNST, DLTR
7/28/2014 11:41:13 AM - BNK Invest

Alexion Looks Better After Q2 Earnings
7/28/2014 10:40:00 AM - Seeking Alpha

Alexion Pharmaceuticals Q2 Earnings In Line; Revises View - Analyst Blog
7/24/2014 3:45:00 PM - Zacks.com

Alexion Pharmaceuticals Q2 14 Earnings Conference Call At 10:00 AM ET
7/24/2014 9:01:00 AM - RTT News

Alexion Q2 Results Top View, Boosts FY14 Outlook - Quick Facts
7/24/2014 6:41:00 AM - RTT News

Will Alexion Pharmaceuticals (ALXN) Miss This Earnings Season? - Analyst Blog
7/23/2014 5:40:00 PM - Zacks.com

Pre-Market Earnings Report for July 24, 2014 : MMM, UNP, BMY, LLY, CELG, F, CAT, GM, PCP, ALXN, POT, RTN
7/23/2014 4:00:05 PM - NASDAQ.com News

Biotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 3 - Analyst Blog
7/23/2014 2:15:00 PM - Zacks.com

Nasdaq 100 Movers: NFLX, WYNN
7/22/2014 12:22:57 PM - BNK Invest

Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?
7/21/2014 10:40:00 AM - Seeking Alpha